Volume Alert - ACHN 13.07 Achillion Pharmaceuticals $ACHN

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 1:55 PM

Volume Alert - ACHN 13.07 Achillion Pharmaceuticals $ACHN Hit a high today of 13.58 Closing the day 10:30 at 13.07 -0.24 -1.80% With a day low of 13.00 and a total volume of 1,338,954.

ACHN Recent Posts: http://investorshangout.com/Achillion-Pharmac...CHN-53213/

ACHN Achillion Pharmaceuticals Recent Headline News

Regulus To See Further Declines
Richard Pearson - Seeking Alpha - Wed Nov 19, 9:30AM CST
On October 22nd, Regulus Therapeutics (NASDAQ: RGLS ) released its " proof of concept " data for its Hep C drug RG-101. The stock price quickly soared from its prior level of $6-7 to as high as $25 (intra day) as enthusiasm for the drug ran...
ISIS: 50.55 (+0.84), ALNY: 91.00 (+1.05), ACHN: 13.06 (-0.25), RGLS: 16.68 (-1.44)

Nasdaq stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ESCA: 12.63 (-0.27), IMDZ: 32.31 (-2.24), OLED: 27.94 (-0.18), FUEL: 17.05 (-0.49), CZR: 14.84 (-0.48), NTIC: 21.46 (+0.46), RESN: 8.60 (+0.66), OREX: 5.72 (+0.10), VBFC: 20.25 (+0.75), FLML: 13.52 (+0.32), ACHN: 13.06 (-0.25), RDI: 11.69 (-0.08), AMOT: 19.89 (-0.21), SUSQ: 13.09 (-0.01), RDIB: 11.84 (-0.16)

Profit taking sinks Achillion
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 12:48PM CST

ACHN: 13.06 (-0.25)

5 Momentum Stocks Currently on the Move with More Potential Upside
at The Street - Thu Nov 13, 11:34AM CST
Achillion, Groupon, Orexigen, Rackspace and TG Therapeutics have had strong recent moves and are showing no sign of slowing.
OREX: 5.72 (+0.10), RAX: 43.27 (+0.57), ACHN: 13.06 (-0.25), TGTX: 14.74 (-0.03), GRPN: 7.36 (-0.01)

Will Achillion Pharmaceuticals (ACHN) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:25AM CST
Will Achillion Pharmaceuticals (ACHN) Continue to Surge Higher?
ACHN: 13.06 (-0.25)

Achillion Pharmaceuticals: Still Bullish, But Taking Profits
Dr. Paul Nunzio DeSantis, Pharm.D - Seeking Alpha - Wed Nov 12, 4:06PM CST
By Dr. Paul Nunzio De Santis (Pharm.D.) Entry: $9.86 10/2/14 Take Profits: $14.45 11/12/14 Hold 10-20% of profits into event for M&A upside. Achillion (NASDAQ: ACHN ) has been a stellar performer since we wrote about it on October 2nd- up...
ACHN: 13.06 (-0.25), MRK: 59.53 (-0.36), ABBV: 65.60 (-0.45)

Achillion Pharmaceuticals (ACHN) Stock Rises on Positive Hepatitis C Drug Results
at The Street - Wed Nov 12, 10:57AM CST
Shares of Achillion Pharmaceuticals (ACHN) continued to rise Wednesday after the company reported encouraging interim results from a Phase II study of its hepatitis C drug ACH-3102.
ACHN: 13.06 (-0.25)

Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Nov 12, 7:48AM CST
Companies like AbbVie (ABBV), Gilead (GILD) and Achillion (ACHN) had a strong presence at the annual Liver Meeting.
VRTX: 114.60 (+3.56), GILD: 102.19 (-1.52), ACHN: 13.06 (-0.25), DNDN: 0.13 (-0.02), AMGN: 162.82 (+0.58), ABBV: 65.60 (-0.45), REGN: 416.98 (+3.76)

This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success
Todd Campbell, The Motley Fool - Motley Fool - Wed Nov 12, 7:43AM CST
Source: Gilead Sciences. Developing drugs that help established blockbusters work better is a major trend in biotechnology. It's a lower-stakes game because drug developers only need to show that their products can improve upon existing therapies,...
GILD: 102.19 (-1.52), ACHN: 13.06 (-0.25), MRK: 59.53 (-0.36)

Most active Nasdaq-traded stocks
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
FB: 73.87 (-0.47), ACHN: 13.06 (-0.25), DNDN: 0.13 (-0.02), CMCSK: 54.00 (-0.21), ARCP: 8.74 (-0.08), ZNGA: 2.71 (unch), MSFT: 48.15 (-0.59), INTC: 34.39 (-0.32), GRPN: 7.36 (-0.01), CMCSA: 54.16 (-0.26), AAPL: 115.01 (-0.46), CSCO: 26.50 (-0.09)

Achillion Jumps on Encouraging Data on its HCV Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 4:10PM CST
Shares of Achillion Pharmaceuticals (ACHN) soared over 27% after the company reported encouraging interim results on ACH-3102.
JNJ: 108.28 (-0.55), GILD: 102.19 (-1.52), ACHN: 13.06 (-0.25), AMAG: 35.66 (+0.32)

Why Is Gilead Always Holding The Ace? A Prediction Of The Future HCV Market And What Analysts Aren't Talking About
Pharma Doc - Seeking Alpha - Tue Nov 11, 10:13AM CST
No matter when you've followed Gilead (NASDAQ: GILD ) over the past decade, they always seem to be holding the ace. Whether in the HIV arena or now in HCV, the Gilead management is always one step ahead and is planning to dominate its market. Gilead...
GILD: 102.19 (-1.52), ACHN: 13.06 (-0.25), MRK: 59.53 (-0.36), ABBV: 65.60 (-0.45), BMY: 58.60 (-0.10)

Gilead presents Harvoni data
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:03AM CST

JNJ: 108.28 (-0.55), GILD: 102.19 (-1.52), ACHN: 13.06 (-0.25), CNAT: 7.13 (+0.06), MRK: 59.53 (-0.36), RGLS: 16.68 (-1.44), ABBV: 65.60 (-0.45), BMY: 58.60 (-0.10), ENTA: 44.27 (+0.57)

AbbVie presents HCV/HIV and liver transplant HCV data
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 9:07AM CST

JNJ: 108.28 (-0.55), GILD: 102.19 (-1.52), ACHN: 13.06 (-0.25), CNAT: 7.13 (+0.06), MRK: 59.53 (-0.36), RGLS: 16.68 (-1.44), ABBV: 65.60 (-0.45), BMY: 58.60 (-0.10), ENTA: 44.27 (+0.57)

Merck presents data from its investigational HCV combo
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:37AM CST

JNJ: 108.28 (-0.55), GILD: 102.19 (-1.52), ACHN: 13.06 (-0.25), CNAT: 7.13 (+0.06), MRK: 59.53 (-0.36), LGND: 54.58 (-0.01), RGLS: 16.68 (-1.44), ABBV: 65.60 (-0.45), BMY: 58.60 (-0.10), ENTA: 44.27 (+0.57)

Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Nov 11, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for ACHN, CLDX, KNDI, ILMN and AMD.
KNDI: 14.46 (-0.28), AMD: 2.63 (-0.02), ACHN: 13.06 (-0.25), CLDX: 19.15 (+1.43), ILMN: 190.64 (+0.79)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ouma Connect Streamlines Surrogacy Medical Clearance

A Game Changer for Surrogacy Agencies When we talk about innovation, we often focus on the flashiest tech in finance or the buzz of a scorching hot stock. But here's Ouma Health, shifting gears in a sector many traders don't blink at—surrogacy. They're unveiling Ouma Connect, a portal pulling back the curtain on medical clearances for gestational-carrier candidates....

ASICS and University of Michigan Launch Innovation Lab

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Utopia Bagels Honored at 2026 New York BagelFest

From Queens Streets to Global Fame Try to picture this: a small neighborhood shop where the scent of freshly baked bagels wafts through, bringing together old friends and new generations. Now, take that local magic and multiply it by a global stage. That's the journey Utopia Bagels from Queens stepped into with massive strides over 45 years, earning a celebrated spot in...

Medline's Decade-Long WRAP Partnership: More Than Labels

A Decade of Trust and Responsibility Here we go, folks—Medline is toasting 10 years with WRAP, and this ain't just fluffy PR spin. When two big players like these lock arms over responsible manufacturing, it's a signal worth paying attention to, and not just for the ethics alone. Production practices that prioritize transparency and worker rights have ramifications...

Touchmark's Q3 Bonanza: Income Leaps 39%, Stock Repurchase

Ever seen a bank juggle financials like a street performer with flaming torches? That's Touchmark Bancshares for you this quarter. This Georgia-based community bank just released their third quarter 2026 results, and it seems they've not only mastered performance but also pranced around market risks effortlessly, much to the delight of investors. Breaking Down the Numbers...

Huntington Bank Bolsters Westside Future Fund with $1M Boost

Huntington's Commitment Goes Beyond Dollars In a world where corporations often toss out pretty phrases without the substance to back them up, Huntington Bank's $1 million shout-out to Atlanta's Westside Future Fund (WFF) speaks volumes. This ain't your run-of-the-mill PR move. It's a solid, tangible effort to help a community that's rich in history but screaming for...

Unlock Technologies Secures $433.1M in HEA Securitization

An Unconventional Wave of Funding Ain't it a sight to see? One year you're hawking tech stocks, the next, you're up to your elbows in home equity agreements (HEAs). That's where Unlock Technologies finds itself. They've just wrapped up their ninth HEA securitization, a hefty $433.1 million, under the watchful eye of D2 Asset Management. This is no minor league...

China's 15th Plan: Key Moves in the Capital Markets

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Massive $1B Jobs Initiative Fights AI Automation Impact

Initiative Tackles Economic Shifts Head-On AI and automation are turning the job market upside down, and more than 20 foundations and philanthropies are throwing their weight behind a $1 billion initiative called All In For Jobs. Their aim? Connect half a million Americans to stable, decent-paying jobs and prepare communities to face the daunting transition imposed by...

HCLTech Partners with Rapidus on Semiconductor Future

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...